Developer docs
API playgroundTry for free, no card

Search company profiles

Doctornow

Full company profile

uuid0002bhu

Namestring
Doctornow
Legal namestring
(주) 닥터나우
Websiteurl
doctornow.co.kr
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Doctornow (legal name: 닥터나우) is a South Korea-based telemedicine platform founded in 2019 and headquartered in Seoul, operating as a mobile-first, self-serve application for remote medical consultations. The platform connects individual patients with a nationwide network of 6,200+ affiliated medical institutions and 23,931 dispensing pharmacies, enabling phone-based or video-based consultations 24 hours a day, 365 days a year. Core service categories include pediatrics, cold/flu treatment, internal medicine, gynecology, hair loss, acne, obesity (including GLP-1 injections such as Mounjaro), and artificial tears, with electronic prescription transmission to partner pharmacies and integrated pharmacy finder and hospital search modules.

The underlying technology stack is centered on a mobile application workflow that handles appointment booking, automated doctor scheduling, real-time prescription generation, and digital transmission of prescriptions to pharmacies, with automatic fax integration compliant with Ministry of Health and Welfare guidelines. Supporting content assets include a health magazine, medicine dictionary, disease encyclopedia, real-time medical Q&A, and a symptom search feature, all of which drive top-of-funnel organic acquisition. The platform also offers a web-based interface at doctornow.co.kr for browser access.

Doctornow monetizes primarily through per-consultation fees ranging from 2,500 KRW to 10,000 KRW depending on treatment type (e.g., 2,500 KRW for hair loss, 3,000 KRW for acne, 5,000-10,000 KRW for obesity injections), positioning itself at a 50-76% discount to Seoul market averages. Secondary revenue flows from prescription drug distribution through its affiliated pharmacy network. The platform serves multiple consumer segments including parents with young children, working professionals, rural residents with limited medical access, and patients with chronic non-benefit conditions. Distribution is exclusively direct-to-consumer via mobile app and web, with no enterprise or institutional channels. The company has raised approximately $41.6M USD across multiple funding rounds between 2021 and 2025, with the June 2022 Series B of $31M USD being the largest, from investors including CRIT Ventures, Hashed, Mirae Asset Capital, SBVA, Naver, Goodwater Capital, and Sazze Partners.

Short descriptiontext

Doctornow is a South Korean mobile telemedicine platform enabling 24/7 phone and video consultations with affiliated doctors, electronic prescriptions, and nationwide pharmacy delivery, serving individual consumers across minor illness, pediatric, and chronic condition categories.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
telemedicine services, mobile health platform, remote medical consultations, electronic prescriptions, pharmacy delivery
Industry3 codes
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAK
Dermatology & Acne Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAJ
Men’s Health Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
NAICS code1 code
  • Offices of Physicians (except Mental Health Specialists)621111
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Telemedicine Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Telemedicine Consultation Fees
TypeTransaction Fee
Description

Patients pay consultation fees to receive phone-based medical consultations with affiliated doctors. The platform aggregates doctors across various specialties including internal medicine, pediatrics, dermatology, and more.

doctornow.co.kr
2Prescription Drug Distribution
TypeTransaction Fee
Description

The platform facilitates prescription drug delivery through affiliated pharmacies. Note: This is subject to regulatory scrutiny as the 'DoctorNow Prevention Act' aims to ban telemedicine platforms from operating drug-wholesale businesses.

koreabiomed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details4 tiers
1Non-benefit medical consultations (hair loss, obesity, acne)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Hair loss consultation (Propecia, etc.): consultation fees from 2,500 KRW; Acne consultation (Isotretinoin, etc.): consultation fees from 3,000 KRW; Obesity injection (Mounjaro): consultation fees from 5,000 KRW for 4-pen prescription

doctornow.co.kr
2Hair loss medication consultation - Seoul region
ModelUnit PricingBilling cadencePay-as-you-go
Notes

1-month prescription consultation: 2,500 KRW (vs Seoul average 10,380 KRW). The platform offers significantly lower prices than market averages.

doctornow.co.kr
3Obesity injection (Mounjaro) - Seoul region
ModelUnit PricingBilling cadencePay-as-you-go
Notes

4-pen prescription consultation: 5,000 KRW (vs Seoul average 18,960 KRW). 8-pen: 7,500 KRW. 12-pen: 10,000 KRW.

doctornow.co.kr
4Acne medication consultation - Seoul region
ModelUnit PricingBilling cadencePay-as-you-go
Notes

1-month prescription consultation: 3,000 KRW (vs Seoul average 11,440 KRW).

doctornow.co.kr
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Doctornow operates a mobile telemedicine platform that connects individual patients with affiliated doctors for 24/7 phone or video-based remote medical consultations across specialties including internal medicine, pediatrics, dermatology, gynecology, and non-benefit treatments such as hair loss, acne, and obesity. Prescriptions are electronically transmitted to a nationwide network of 23,931 partner pharmacies for medication pickup, with the platform promoting consultation fees substantially below Seoul market averages.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 66%+ repeat-use rate for minor illnesses
+4 more records
Product overview1 text field

Doctornow is a telemedicine platform offering phone-based and video-based remote medical consultations accessible 365 days, 24 hours a day. The platform connects patients with over 6,200 affiliated medical institutions and coordinates with 23,931 dispensing pharmacies for prescription fulfillment. The core offering includes 비대면 진료 (Telemedicine Services) for common conditions such as cold/flu, pediatrics, gynecology, internal medicine, hair loss, acne, obesity/weight management, and artificial tears. Additional features include hospital and pharmacy search directories, real-time medical Q&A, a health magazine with editor-curated content, a medicine dictionary, and a disease encyclopedia. The platform operates primarily in South Korea with pricing transparency features comparing treatment costs across regions.

Product and service9 records
1Doctornow Telemedicine Service (비대면 진료)
CategoryTelemedicine
Description

Remote medical consultation service available via phone or video 24/7 year-round, pairing patients with affiliated doctors for diagnosis and electronic prescriptions transmitted to partner pharmacies.

2Cold and Flu Treatment Service (감기/독감 진료)
CategoryTelemedicine - Respiratory
Description

Remote consultation service for cold and flu symptoms, with electronic prescription transmission to affiliated pharmacies for medication pickup.

3Pediatric Telemedicine Service (소아청소년과 진료)
CategoryTelemedicine - Pediatrics
Description

Pediatric telemedicine consultations covering children's health issues including cold, fever, diarrhea, and skin rashes, designed for parents who need care without clinic visits.

4Hair Loss Treatment Service (탈모 진료)
CategoryTelemedicine - Dermatology / Non-benefit
Description

Telemedicine consultations for androgenic alopecia providing prescriptions for hair loss medications such as Propecia (Finasteride) and Dutasteride at significantly below Seoul market average pricing.

5Acne Treatment Service (여드름 진료)
CategoryTelemedicine - Dermatology / Non-benefit
Description

Telemedicine consultation for acne that prescribes medications such as Isotretinoin (Isotoin, Nimegen) at consult fees significantly below Seoul market averages.

6Artificial Tears / Dry Eye Service (인공눈물 진료)
CategoryTelemedicine - Ophthalmology
Description

Telemedicine service for dry eye treatment providing prescriptions for artificial tears delivered through the platform's pharmacy network.

7Diet and Obesity Treatment Service (다이어트/비만 진료)
CategoryTelemedicine - Weight Management / Non-benefit
Description

Weight management consultations including prescription of obesity injections such as MAUNJARO (Tirzepatide), with tiered pen-count packages (4/8/12-pen) priced well below Seoul market averages.

8Gynecology Telemedicine Service (산부인과 진료)
CategoryTelemedicine - Gynecology
Description

Telemedicine service for women's health issues including vaginitis, bladder infections, and menstrual pain, allowing female patients privacy and convenience versus in-person visits.

9Internal Medicine Telemedicine Service (내과 진료)
CategoryTelemedicine - Internal Medicine
Description

General internal medicine consultations delivered via the platform, covering common adult conditions addressed through phone or video visits.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-25
Description

Doctor Now acquired healthcare startup Boosters Company, which offers personalized exercise and health management services. The acquisition aimed to enhance non-face-to-face medical and prescription drug services. Kim Jong-sang, Boosters' CEO and founder, was appointed as Chief Product Officer of Doctor Now to lead service development efforts.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-listed DTC telehealth + online pharmacy focused on hair loss, dermatology, sexual health, and weight management. Closest international analog to Doctornow's non-benefit, cash-pay, pharmacy-integrated model.

2Ro
TypeDirect peer
Description

US-based DTC telehealth and pharmacy platform with strong positions in men's health (Roman), dermatology, and GLP-1 weight loss. Highly comparable business model and category mix to Doctornow.

TypeBroad incumbent
Description

Largest global telehealth incumbent offering virtual care across primary, specialty, and mental health. Comparable in category but broader, enterprise-led, and far larger scale than Doctornow.

TypeDirect peer
Description

Healthcare arm of Kakao, operating Korean DTC telemedicine and pharmacy-related services. Direct competitor leveraging Kakao's super-app distribution and payments.

TypeDirect peer
Description

NAVER's telemedicine offering, backed by Korea's largest portal and search user base. Competes head-on with Doctornow for DTC consultation volume and doctor supply.

6Doctor Anywhere
TypeRegional player
Description

Singapore-headquartered DTC telemedicine platform with operations across Southeast Asia. Comparable mobile-first, cash-pay, multi-specialty virtual care model to Doctornow, but focused on SEA rather than Korea.

TypeRegional player
Description

Indonesia's leading telehealth + pharmacy delivery app. Highly comparable business model (consult → e-prescription → medicine delivery) targeting a different geography from Doctornow.

TypeRegional player
Description

China's largest online healthcare platform, combining telemedicine, e-pharmacy, and in-person clinic network. Comparable in scale of network (doctors, pharmacies) but operating under Chinese regulatory regime.

TypeEmerging player
Description

European DTC telehealth and online clinic offering consultations with prescription delivery across the UK and EU. Shares Doctornow's cash-pay, prescription-forward model but in a different regulatory environment.

TypeBroad incumbent
Description

US-listed enterprise telehealth platform partnering with health systems and insurers. Overlaps with Doctornow on virtual consultations but operates a B2B2C model rather than pure DTC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Doctornow

Telemedicine Servicesdoctornow.co.kr

Doctornow is a South Korean mobile telemedicine platform enabling 24/7 phone and video consultations with affiliated doctors, electronic prescriptions, and nationwide pharmacy delivery, serving individual consumers across minor illness, pediatric, and chronic condition categories.

What Doctornow does

Doctornow (legal name: 닥터나우) is a South Korea-based telemedicine platform founded in 2019 and headquartered in Seoul, operating as a mobile-first, self-serve application for remote medical consultations. The platform connects individual patients with a nationwide network of 6,200+ affiliated medical institutions and 23,931 dispensing pharmacies, enabling phone-based or video-based consultations 24 hours a day, 365 days a year. Core service categories include pediatrics, cold/flu treatment, internal medicine, gynecology, hair loss, acne, obesity (including GLP-1 injections such as Mounjaro), and artificial tears, with electronic prescription transmission to partner pharmacies and integrated pharmacy finder and hospital search modules.

The underlying technology stack is centered on a mobile application workflow that handles appointment booking, automated doctor scheduling, real-time prescription generation, and digital transmission of prescriptions to pharmacies, with automatic fax integration compliant with Ministry of Health and Welfare guidelines. Supporting content assets include a health magazine, medicine dictionary, disease encyclopedia, real-time medical Q&A, and a symptom search feature, all of which drive top-of-funnel organic acquisition. The platform also offers a web-based interface at doctornow.co.kr for browser access.

Doctornow monetizes primarily through per-consultation fees ranging from 2,500 KRW to 10,000 KRW depending on treatment type (e.g., 2,500 KRW for hair loss, 3,000 KRW for acne, 5,000-10,000 KRW for obesity injections), positioning itself at a 50-76% discount to Seoul market averages. Secondary revenue flows from prescription drug distribution through its affiliated pharmacy network. The platform serves multiple consumer segments including parents with young children, working professionals, rural residents with limited medical access, and patients with chronic non-benefit conditions. Distribution is exclusively direct-to-consumer via mobile app and web, with no enterprise or institutional channels. The company has raised approximately $41.6M USD across multiple funding rounds between 2021 and 2025, with the June 2022 Series B of $31M USD being the largest, from investors including CRIT Ventures, Hashed, Mirae Asset Capital, SBVA, Naver, Goodwater Capital, and Sazze Partners.

Doctornow firmographics

Firmographics
Name
Doctornow
Legal name
(주) 닥터나우
Website
https://doctornow.co.kr
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Doctornow is a South Korean mobile telemedicine platform enabling 24/7 phone and video consultations with affiliated doctors, electronic prescriptions, and nationwide pharmacy delivery, serving individual consumers across minor illness, pediatric, and chronic condition categories.
Ownership category
akta.pro rank

Doctornow industry classification

Industry
Product category
Telemedicine Services
NAICS
Offices of Physicians (except Mental Health Specialists) (621111)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAK
Dermatology & Acne Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAJ
Men’s Health Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

  • Telemedicine services
  • Mobile health platform
  • Remote medical consultations
  • Electronic prescriptions
  • Pharmacy delivery

Where Doctornow is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Markets served

Doctornow business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Telemedicine Consultation Fees: Patients pay consultation fees to receive phone-based medical consultations with affiliated doctors. The platform aggregates doctors across various specialties including internal medicine, pediatrics, dermatology, and more.
  2. Prescription Drug Distribution: The platform facilitates prescription drug delivery through affiliated pharmacies. Note: This is subject to regulatory scrutiny as the 'DoctorNow Prevention Act' aims to ban telemedicine platforms from operating drug-wholesale businesses.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goNon-benefit medical consultations (hair loss, obesity, acne)
Unit PricingPay-as-you-goHair loss medication consultation - Seoul region
Unit PricingPay-as-you-goObesity injection (Mounjaro) - Seoul region
Unit PricingPay-as-you-goAcne medication consultation - Seoul region

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Doctornow product offering

Product offering

Core offering

Doctornow operates a mobile telemedicine platform that connects individual patients with affiliated doctors for 24/7 phone or video-based remote medical consultations across specialties including internal medicine, pediatrics, dermatology, gynecology, and non-benefit treatments such as hair loss, acne, and obesity. Prescriptions are electronically transmitted to a nationwide network of 23,931 partner pharmacies for medication pickup, with the platform promoting consultation fees substantially below Seoul market averages.

Product overview

Doctornow is a telemedicine platform offering phone-based and video-based remote medical consultations accessible 365 days, 24 hours a day. The platform connects patients with over 6,200 affiliated medical institutions and coordinates with 23,931 dispensing pharmacies for prescription fulfillment. The core offering includes 비대면 진료 (Telemedicine Services) for common conditions such as cold/flu, pediatrics, gynecology, internal medicine, hair loss, acne, obesity/weight management, and artificial tears. Additional features include hospital and pharmacy search directories, real-time medical Q&A, a health magazine with editor-curated content, a medicine dictionary, and a disease encyclopedia. The platform operates primarily in South Korea with pricing transparency features comparing treatment costs across regions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Doctornow Telemedicine Service (비대면 진료) Remote medical consultation service available via phone or video 24/7 year-round, pairing patients with affiliated doctors for diagnosis and electronic prescriptions transmitted to partner pharmacies.
  • Cold and Flu Treatment Service (감기/독감 진료) Remote consultation service for cold and flu symptoms, with electronic prescription transmission to affiliated pharmacies for medication pickup.
  • Pediatric Telemedicine Service (소아청소년과 진료) Pediatric telemedicine consultations covering children's health issues including cold, fever, diarrhea, and skin rashes, designed for parents who need care without clinic visits.
  • Hair Loss Treatment Service (탈모 진료) Telemedicine consultations for androgenic alopecia providing prescriptions for hair loss medications such as Propecia (Finasteride) and Dutasteride at significantly below Seoul market average pricing.
  • Acne Treatment Service (여드름 진료) Telemedicine consultation for acne that prescribes medications such as Isotretinoin (Isotoin, Nimegen) at consult fees significantly below Seoul market averages.
  • Artificial Tears / Dry Eye Service (인공눈물 진료) Telemedicine service for dry eye treatment providing prescriptions for artificial tears delivered through the platform's pharmacy network.
  • Diet and Obesity Treatment Service (다이어트/비만 진료) Weight management consultations including prescription of obesity injections such as MAUNJARO (Tirzepatide), with tiered pen-count packages (4/8/12-pen) priced well below Seoul market averages.
  • Gynecology Telemedicine Service (산부인과 진료) Telemedicine service for women's health issues including vaginitis, bladder infections, and menstrual pain, allowing female patients privacy and convenience versus in-person visits.
  • Internal Medicine Telemedicine Service (내과 진료) General internal medicine consultations delivered via the platform, covering common adult conditions addressed through phone or video visits.

Quantifiable outcome

  • 66%+ repeat-use rate for minor illnesses
  • +4 more outcomes

Companies that use Doctornow

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Doctornow technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Doctornow partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Boosters CompanycoreStrategic or Co-development Partner · 25 April 2022Doctor Now acquired healthcare startup Boosters Company, which offers personalized exercise and health management services. The acquisition aimed to enhance non-face-to-face medical and prescription drug services. Kim Jong-sang, Boosters' CEO and founder, was appointed as Chief Product Officer of Doctor Now to lead service development efforts.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Doctornow competitors and assessment

Company assessment

Direct peers

  • Hims & Hers Health: US-listed DTC telehealth + online pharmacy focused on hair loss, dermatology, sexual health, and weight management. Closest international analog to Doctornow's non-benefit, cash-pay, pharmacy-integrated model.
  • Ro: US-based DTC telehealth and pharmacy platform with strong positions in men's health (Roman), dermatology, and GLP-1 weight loss. Highly comparable business model and category mix to Doctornow.
  • Kakao Healthcare: Healthcare arm of Kakao, operating Korean DTC telemedicine and pharmacy-related services. Direct competitor leveraging Kakao's super-app distribution and payments.
  • NAVER Doctor (NAVER Health): NAVER's telemedicine offering, backed by Korea's largest portal and search user base. Competes head-on with Doctornow for DTC consultation volume and doctor supply.

Broad incumbents

  • Teladoc Health: Largest global telehealth incumbent offering virtual care across primary, specialty, and mental health. Comparable in category but broader, enterprise-led, and far larger scale than Doctornow.
  • Amwell: US-listed enterprise telehealth platform partnering with health systems and insurers. Overlaps with Doctornow on virtual consultations but operates a B2B2C model rather than pure DTC.

Regional players

  • Doctor Anywhere: Singapore-headquartered DTC telemedicine platform with operations across Southeast Asia. Comparable mobile-first, cash-pay, multi-specialty virtual care model to Doctornow, but focused on SEA rather than Korea.
  • Halodoc: Indonesia's leading telehealth + pharmacy delivery app. Highly comparable business model (consult → e-prescription → medicine delivery) targeting a different geography from Doctornow.
  • Ping An Good Doctor (Ping An Healthcare and Technology): China's largest online healthcare platform, combining telemedicine, e-pharmacy, and in-person clinic network. Comparable in scale of network (doctors, pharmacies) but operating under Chinese regulatory regime.

Emerging players

  • Zava: European DTC telehealth and online clinic offering consultations with prescription delivery across the UK and EU. Shares Doctornow's cash-pay, prescription-forward model but in a different regulatory environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Doctornow social profiles

Digital presence

Doctornow financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Doctornow leadership team

Management profile

Number of profiles

Profiles3 records

Doctornow subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Doctornow funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Doctornow M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doctornow

What does Doctornow do?

Doctornow operates a mobile telemedicine platform that connects individual patients with affiliated doctors for 24/7 phone or video-based remote medical consultations across specialties including internal medicine, pediatrics, dermatology, gynecology, and non-benefit treatments such as hair loss, acne, and obesity. Prescriptions are electronically transmitted to a nationwide network of 23,931 partner pharmacies for medication pickup, with the platform promoting consultation fees substantially below Seoul market averages.

Is Doctornow a public or private company?

Doctornow is a private company. It is classified as venture growth investor backed and is currently operating.

When was Doctornow founded?

Doctornow was founded in 2019. It employs 11 to 50 people.

Where is Doctornow based?

Doctornow is headquartered in Seoul, South Korea, in the Asia region.

How does Doctornow make money?

Two revenue lines are on record. Telemedicine Consultation Fees are the primary driver. The others are prescription Drug Distribution.

Who are Doctornow's main competitors?

Direct peers on record are Hims & Hers Health, Ro, Kakao Healthcare and NAVER Doctor (NAVER Health). Broad incumbents are Teladoc Health and Amwell. Regional players are Doctor Anywhere, Halodoc and Ping An Good Doctor (Ping An Healthcare and Technology). Zava is listed as an emerging player.

Does Doctornow have an API?

No public API is recorded for Doctornow.

What industry is Doctornow in?

Doctornow's product category is Telemedicine Services. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAIAK, Dermatology & Acne Prescribing + Pharmacy Delivery Platforms. Its NAICS code is 621111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nate[Exclusive] Report of 'bomb installation' at Doctor Now building... Police identify the extortionist: Nate NewsPolice searched Doctor Now's Samsung-dong office after a message claimed an explosive was installed, but no explosives were found. The investigation continues to identify the sender of the threatening message, with charges of public intimidation under consideration.Nate[Gwanghwamun] The Tada incident is ongoing: Nate NewsLee So-young, nominee for Minister of SMEs and Startups, said she will prevent a second Tada incident. The article cites Doctor Now's forced closure and Lucent Block's setback as examples of innovation blocked by vested interests. It calls for legal guarantees for sandbox pioneers and prioritizing consumer benefits.VenturesquareDoctor Now, a documentary showcasing the medical accessibility of four patients, is released.Doctor Now released a three-minute documentary on September 3 featuring four patients' telemedicine experiences, including a caregiver, underserved-area patient, self-employed person, and working mother. The company plans to use this data for policy communication during the December implementation of subordinate medical regulations.PlatumStart a business, but don't collide.On August 20, the government began recruiting 10,000 challengers for the second phase of the 'Everyone's Startup' project, while the National Assembly passed a bill amending the Pharmacists Act to restrict non-face-to-face pharmaceutical wholesale. The bill, called the 'Doctor Now Prevention Law,' targets a single company, Doctor Now, raising concerns about setting a precedent for company-specific regulations.KBRTelemedicine platform Doctornow forced out of drug wholesaling under new lawSouth Korea's National Assembly passed an amendment to the Pharmaceutical Affairs Act barring telemedicine intermediary service providers from operating pharmaceutical wholesalers, with 95 votes in favor, 34 against and 49 abstentions. The law, dubbed the "Doctornow prevention law," also tightens narcotic and psychotropic drug controls. It takes effect one year after promulgation.KBRTelemedicine platform Doctornow forced out of drug wholesaling under new lawThe National Assembly passed an amendment to the Pharmaceutical Affairs Act that bars telemedicine platforms, including Doctornow, from operating pharmaceutical wholesale businesses. This legislation was enacted following scrutiny over potential conflicts of interest involving Doctornow's subsidiary, Bijin Pharm. While blocking direct wholesaling, the bill supports the government's parallel initiative to institutionalize prescription drug delivery for all telemedicine patients.NateThe 'Doctor Now Prevention Act' barely passed... The reason why 26 members of the ruling party opposed or abstained despite proposing it: Nate NewsSouth Korea's National Assembly passed an amendment to the Pharmaceutical Affairs Act, commonly known as the 'Doctor Now Prevention Act,' which prohibits non-face-to-face medical service platforms like Doctor Now from establishing pharmaceutical wholesalers. The legislation aims to prevent potential unfair rebate practices but faced opposition from 26 ruling party members who argued it constitutes ex post regulation that harms the startup ecosystem and patient welfare. This regulatory move highlights a sharp divergence between the medical community's desire for strict oversight and the venture industry's concerns over legal certainty.ChosunbizSouth Korea curbs telemedicine wholesalers, moves to formalize deliverySouth Korea's National Assembly passed an amendment to the Pharmaceutical Affairs Act that bars telemedicine platforms, specifically targeting Dr. Now, from obtaining pharmaceutical wholesaler licenses. The legislation aims to formalize medication delivery processes and enhance safety by requiring pharmacists to check patient histories via the Drug Utilization Review system. While Dr. Now expressed regret over the restriction on its wholesale expansion, it welcomed the government's parallel efforts to improve medication access for telemedicine patients.VenturesquareThe 'Doctor Now Prevention Law' has passed, but will the delivery of medications be expanded?…The conflict between regulations and innovation surrounding non-face-to-face medical treatment.The Pharmaceutical Affairs Act amendment, dubbed the 'Doctor Now Prevention Act,' passed the National Assembly on the 20th, blocking telemedicine platforms' pharmaceutical distribution. The government announced plans to expand drug delivery to all telemedicine patients, with discussions on safety measures. The debate is shifting from whether delivery should occur to how to balance safety and accessibility.VenturesquareDr. Now appoints Jeon Ji-woong, former CMO of Curly... reviving the growth engine.Dr. Now appointed Jeon Ji-woong, former CMO of Kurly, as its CMO. He led B2C marketing for 11 years, helping Kurly grow to 3 trillion won annual revenue. Dr. Now aims to use his data-driven marketing experience to expand its telemedicine user base and improve retention.